The global HEPES market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the HEPES is forecast to a readjusted size of US$ 116.3 million by 2030 with a CAGR of 9.2% during review period.
The research report highlights the growth potential of the global HEPES market. HEPES are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of HEPES. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the HEPES market.
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) is a zwitterionic sulfonic acid buffering agent; one of the twenty Good's buffers. HEPES is widely used in cell culture, largely because it is better at maintaining physiological pH despite changes in carbon dioxide concentration (produced by aerobic respiration) when compared to bicarbonate buffers, which are also commonly used in cell culture.
Global 5 largest manufacturers of HEPES are Merck, Suzhou Yacoo, Hopax, Avantor and ITW Reagents, which make up nearly 40%. Among them, Merck dominates with nearly 10% production value share, followed by Suzhou Yacoo (9%) and Hopax (8%). Top manufacturers are based in North America, China and Europe.
North America is the largest market, holding a share over 40%, followed by China and Europe, with shares 20% and 22% separately.
Based on the product type, the HEPES is primarily split into HEPES Powder and HEPES Solution. The leading type is HEPES Powder, with a market share over 75%.
Based on the Application, the HEPES is primarily split into Cell Culture and IVD Reagents. The largest segment is Cell Culture, accounting for over 50%.
Key Features:
The report on HEPES market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the HEPES market. It may include historical data, market segmentation by Type (e.g., HEPES Powder, HEPES Solution), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the HEPES market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the HEPES market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the HEPES industry. This include advancements in HEPES technology, HEPES new entrants, HEPES new investment, and other innovations that are shaping the future of HEPES.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the HEPES market. It includes factors influencing customer ' purchasing decisions, preferences for HEPES product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the HEPES market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting HEPES market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the HEPES market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the HEPES industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the HEPES market.
Market Segmentation:
HEPES market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
HEPES Powder
HEPES Solution
Segmentation by application
Cell Culture
IVD Reagents
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Thermo Fisher
Avantor
Lonza
Cytiva
Promega
ITW Reagents
Spectrum Chemical
Biological Industries
Bio-Techne
BioSpectra
Corning
FUJIFILM Irvine Scientific
Dojindo Laboratories
Hopax
Suzhou Yacoo
XZL Bio-Technology
Yunbang Bio-pharmaceutical
Nanjing Robiot
Huanggang Yongan
Key Questions Addressed in this Report
What is the 10-year outlook for the global HEPES market?
What factors are driving HEPES market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do HEPES market opportunities vary by end market size?
How does HEPES break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global HEPES Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for HEPES by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for HEPES by Country/Region, 2019, 2023 & 2030
2.2 HEPES Segment by Type
2.2.1 HEPES Powder
2.2.2 HEPES Solution
2.3 HEPES Sales by Type
2.3.1 Global HEPES Sales Market Share by Type (2019-2024)
2.3.2 Global HEPES Revenue and Market Share by Type (2019-2024)
2.3.3 Global HEPES Sale Price by Type (2019-2024)
2.4 HEPES Segment by Application
2.4.1 Cell Culture
2.4.2 IVD Reagents
2.4.3 Others
2.5 HEPES Sales by Application
2.5.1 Global HEPES Sale Market Share by Application (2019-2024)
2.5.2 Global HEPES Revenue and Market Share by Application (2019-2024)
2.5.3 Global HEPES Sale Price by Application (2019-2024)
3 Global HEPES by Company
3.1 Global HEPES Breakdown Data by Company
3.1.1 Global HEPES Annual Sales by Company (2019-2024)
3.1.2 Global HEPES Sales Market Share by Company (2019-2024)
3.2 Global HEPES Annual Revenue by Company (2019-2024)
3.2.1 Global HEPES Revenue by Company (2019-2024)
3.2.2 Global HEPES Revenue Market Share by Company (2019-2024)
3.3 Global HEPES Sale Price by Company
3.4 Key Manufacturers HEPES Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HEPES Product Location Distribution
3.4.2 Players HEPES Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for HEPES by Geographic Region
4.1 World Historic HEPES Market Size by Geographic Region (2019-2024)
4.1.1 Global HEPES Annual Sales by Geographic Region (2019-2024)
4.1.2 Global HEPES Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic HEPES Market Size by Country/Region (2019-2024)
4.2.1 Global HEPES Annual Sales by Country/Region (2019-2024)
4.2.2 Global HEPES Annual Revenue by Country/Region (2019-2024)
4.3 Americas HEPES Sales Growth
4.4 APAC HEPES Sales Growth
4.5 Europe HEPES Sales Growth
4.6 Middle East & Africa HEPES Sales Growth
5 Americas
5.1 Americas HEPES Sales by Country
5.1.1 Americas HEPES Sales by Country (2019-2024)
5.1.2 Americas HEPES Revenue by Country (2019-2024)
5.2 Americas HEPES Sales by Type
5.3 Americas HEPES Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HEPES Sales by Region
6.1.1 APAC HEPES Sales by Region (2019-2024)
6.1.2 APAC HEPES Revenue by Region (2019-2024)
6.2 APAC HEPES Sales by Type
6.3 APAC HEPES Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe HEPES by Country
7.1.1 Europe HEPES Sales by Country (2019-2024)
7.1.2 Europe HEPES Revenue by Country (2019-2024)
7.2 Europe HEPES Sales by Type
7.3 Europe HEPES Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa HEPES by Country
8.1.1 Middle East & Africa HEPES Sales by Country (2019-2024)
8.1.2 Middle East & Africa HEPES Revenue by Country (2019-2024)
8.2 Middle East & Africa HEPES Sales by Type
8.3 Middle East & Africa HEPES Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HEPES
10.3 Manufacturing Process Analysis of HEPES
10.4 Industry Chain Structure of HEPES
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HEPES Distributors
11.3 HEPES Customer
12 World Forecast Review for HEPES by Geographic Region
12.1 Global HEPES Market Size Forecast by Region
12.1.1 Global HEPES Forecast by Region (2025-2030)
12.1.2 Global HEPES Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global HEPES Forecast by Type
12.7 Global HEPES Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck HEPES Product Portfolios and Specifications
13.1.3 Merck HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Thermo Fisher
13.2.1 Thermo Fisher Company Information
13.2.2 Thermo Fisher HEPES Product Portfolios and Specifications
13.2.3 Thermo Fisher HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Thermo Fisher Main Business Overview
13.2.5 Thermo Fisher Latest Developments
13.3 Avantor
13.3.1 Avantor Company Information
13.3.2 Avantor HEPES Product Portfolios and Specifications
13.3.3 Avantor HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Avantor Main Business Overview
13.3.5 Avantor Latest Developments
13.4 Lonza
13.4.1 Lonza Company Information
13.4.2 Lonza HEPES Product Portfolios and Specifications
13.4.3 Lonza HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lonza Main Business Overview
13.4.5 Lonza Latest Developments
13.5 Cytiva
13.5.1 Cytiva Company Information
13.5.2 Cytiva HEPES Product Portfolios and Specifications
13.5.3 Cytiva HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Cytiva Main Business Overview
13.5.5 Cytiva Latest Developments
13.6 Promega
13.6.1 Promega Company Information
13.6.2 Promega HEPES Product Portfolios and Specifications
13.6.3 Promega HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Promega Main Business Overview
13.6.5 Promega Latest Developments
13.7 ITW Reagents
13.7.1 ITW Reagents Company Information
13.7.2 ITW Reagents HEPES Product Portfolios and Specifications
13.7.3 ITW Reagents HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 ITW Reagents Main Business Overview
13.7.5 ITW Reagents Latest Developments
13.8 Spectrum Chemical
13.8.1 Spectrum Chemical Company Information
13.8.2 Spectrum Chemical HEPES Product Portfolios and Specifications
13.8.3 Spectrum Chemical HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Spectrum Chemical Main Business Overview
13.8.5 Spectrum Chemical Latest Developments
13.9 Biological Industries
13.9.1 Biological Industries Company Information
13.9.2 Biological Industries HEPES Product Portfolios and Specifications
13.9.3 Biological Industries HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Biological Industries Main Business Overview
13.9.5 Biological Industries Latest Developments
13.10 Bio-Techne
13.10.1 Bio-Techne Company Information
13.10.2 Bio-Techne HEPES Product Portfolios and Specifications
13.10.3 Bio-Techne HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Bio-Techne Main Business Overview
13.10.5 Bio-Techne Latest Developments
13.11 BioSpectra
13.11.1 BioSpectra Company Information
13.11.2 BioSpectra HEPES Product Portfolios and Specifications
13.11.3 BioSpectra HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 BioSpectra Main Business Overview
13.11.5 BioSpectra Latest Developments
13.12 Corning
13.12.1 Corning Company Information
13.12.2 Corning HEPES Product Portfolios and Specifications
13.12.3 Corning HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Corning Main Business Overview
13.12.5 Corning Latest Developments
13.13 FUJIFILM Irvine Scientific
13.13.1 FUJIFILM Irvine Scientific Company Information
13.13.2 FUJIFILM Irvine Scientific HEPES Product Portfolios and Specifications
13.13.3 FUJIFILM Irvine Scientific HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 FUJIFILM Irvine Scientific Main Business Overview
13.13.5 FUJIFILM Irvine Scientific Latest Developments
13.14 Dojindo Laboratories
13.14.1 Dojindo Laboratories Company Information
13.14.2 Dojindo Laboratories HEPES Product Portfolios and Specifications
13.14.3 Dojindo Laboratories HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Dojindo Laboratories Main Business Overview
13.14.5 Dojindo Laboratories Latest Developments
13.15 Hopax
13.15.1 Hopax Company Information
13.15.2 Hopax HEPES Product Portfolios and Specifications
13.15.3 Hopax HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Hopax Main Business Overview
13.15.5 Hopax Latest Developments
13.16 Suzhou Yacoo
13.16.1 Suzhou Yacoo Company Information
13.16.2 Suzhou Yacoo HEPES Product Portfolios and Specifications
13.16.3 Suzhou Yacoo HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Suzhou Yacoo Main Business Overview
13.16.5 Suzhou Yacoo Latest Developments
13.17 XZL Bio-Technology
13.17.1 XZL Bio-Technology Company Information
13.17.2 XZL Bio-Technology HEPES Product Portfolios and Specifications
13.17.3 XZL Bio-Technology HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 XZL Bio-Technology Main Business Overview
13.17.5 XZL Bio-Technology Latest Developments
13.18 Yunbang Bio-pharmaceutical
13.18.1 Yunbang Bio-pharmaceutical Company Information
13.18.2 Yunbang Bio-pharmaceutical HEPES Product Portfolios and Specifications
13.18.3 Yunbang Bio-pharmaceutical HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Yunbang Bio-pharmaceutical Main Business Overview
13.18.5 Yunbang Bio-pharmaceutical Latest Developments
13.19 Nanjing Robiot
13.19.1 Nanjing Robiot Company Information
13.19.2 Nanjing Robiot HEPES Product Portfolios and Specifications
13.19.3 Nanjing Robiot HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Nanjing Robiot Main Business Overview
13.19.5 Nanjing Robiot Latest Developments
13.20 Huanggang Yongan
13.20.1 Huanggang Yongan Company Information
13.20.2 Huanggang Yongan HEPES Product Portfolios and Specifications
13.20.3 Huanggang Yongan HEPES Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Huanggang Yongan Main Business Overview
13.20.5 Huanggang Yongan Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
